Redeye updates its estimates for Lagercrantz following a Q3 acquisition spree, along with FX adjustments due to the strenghtening SEK. We reiterate our fair value range.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Lagercrantz - Q3 preview

© Modular Finance, source Nordic Press Releases